• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 APC-Asef 相互作用的肽拟似物抑制剂抑制结直肠癌迁移。

Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration.

机构信息

Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Ministry of Education, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.

Department of Biochemistry and Molecular Cell Biology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.

出版信息

Nat Chem Biol. 2017 Sep;13(9):994-1001. doi: 10.1038/nchembio.2442. Epub 2017 Jul 24.

DOI:10.1038/nchembio.2442
PMID:28759015
Abstract

The binding of adenomatous polyposis coli (APC) to its receptor Asef relieves the negative intramolecular regulation of Asef and leads to aberrant cell migration in human colorectal cancer. Because of its crucial role in metastatic dissemination, the interaction between APC and Asef is an attractive target for anti-colorectal-cancer therapy. We rationally designed a series of peptidomimetics that act as potent inhibitors of the APC interface. Crystal structures and biochemical and cellular assays showed that the peptidomimetics in the APC pocket inhibited the migration of colorectal cells by disrupting APC-Asef interaction. By using the peptidomimetic inhibitor as a chemical probe, we found that CDC42 was the downstream GTPase involved in APC-stimulated Asef activation in colorectal cancer cells. Our work demonstrates the feasibility of exploiting APC-Asef interaction to regulate the migration of colorectal cancer cells, and provides what to our knowledge is the first class of protein-protein interaction inhibitors available for the development of cancer therapeutics targeting APC-Asef signaling.

摘要

腺瘤性结肠息肉病(APC)与受体 Asef 的结合解除了 Asef 的负分子内调节,导致人结直肠癌细胞的异常迁移。由于 APC 和 Asef 之间的相互作用在转移扩散中起着至关重要的作用,因此该相互作用是抗结直肠癌治疗的一个有吸引力的靶点。我们合理设计了一系列拟肽,这些拟肽可作为 APC 界面的有效抑制剂。晶体结构以及生化和细胞测定表明,APC 口袋中的拟肽通过破坏 APC-Asef 相互作用抑制结直肠细胞的迁移。通过将肽模拟抑制剂用作化学探针,我们发现 CDC42 是涉及结直肠癌细胞中 APC 刺激的 Asef 激活的下游 GTPase。我们的工作证明了利用 APC-Asef 相互作用来调节结直肠癌细胞迁移的可行性,并提供了据我们所知的针对 APC-Asef 信号靶向癌症治疗的第一种蛋白质-蛋白质相互作用抑制剂。

相似文献

1
Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration.靶向 APC-Asef 相互作用的肽拟似物抑制剂抑制结直肠癌迁移。
Nat Chem Biol. 2017 Sep;13(9):994-1001. doi: 10.1038/nchembio.2442. Epub 2017 Jul 24.
2
Truncated Adenomatous Polyposis Coli Mutation Induces Asef-Activated Golgi Fragmentation.截短型腺瘤性结肠息肉病 coli 突变诱导 Asef 激活的高尔基体碎片化。
Mol Cell Biol. 2018 Aug 15;38(17). doi: 10.1128/MCB.00135-18. Print 2018 Sep 1.
3
Rational design of a sensitivity-enhanced tracer for discovering efficient APC-Asef inhibitors.用于发现高效 APC-Asef 抑制剂的敏感性增强示踪剂的合理设计。
Nat Commun. 2022 Aug 24;13(1):4961. doi: 10.1038/s41467-022-32612-6.
4
Design, synthesis and biological evaluation of 2-H pyrazole derivatives containing morpholine moieties as highly potent small molecule inhibitors of APC-Asef interaction.设计、合成并评价含吗啉基的 2-H 吡唑衍生物作为 APC-Asef 相互作用的高活性小分子抑制剂。
Eur J Med Chem. 2019 Sep 1;177:425-447. doi: 10.1016/j.ejmech.2019.05.056. Epub 2019 May 26.
5
Rational Design and Structure Validation of a Novel Peptide Inhibitor of the Adenomatous-Polyposis-Coli (APC)-Rho-Guanine-Nucleotide-Exchange-Factor-4 (Asef) Interaction.新型腺瘤性息肉病大肠杆菌(APC)-Rho-鸟嘌呤核苷酸交换因子-4(Asef)相互作用肽抑制剂的合理设计与结构验证。
J Med Chem. 2018 Sep 13;61(17):8017-8028. doi: 10.1021/acs.jmedchem.8b01112. Epub 2018 Aug 20.
6
Advances and Insights of APC-Asef Inhibitors for Metastatic Colorectal Cancer Therapy.用于转移性结直肠癌治疗的APC-Asef抑制剂的进展与见解
Front Mol Biosci. 2021 Apr 22;8:662579. doi: 10.3389/fmolb.2021.662579. eCollection 2021.
7
Structural basis for the recognition of Asef by adenomatous polyposis coli.Asef 被腺瘤性结肠息肉病基因识别的结构基础。
Cell Res. 2012 Feb;22(2):372-86. doi: 10.1038/cr.2011.119. Epub 2011 Jul 26.
8
Differences in the localization of the adenomatous polyposis coli-Asef/Asef2 complex between adenomatous polyposis coli wild-type and mutant cells.腺瘤性结肠息肉病 APC-Asef/Asef2 复合物在腺瘤性结肠息肉病野生型和突变型细胞中的定位差异。
Cancer Sci. 2013 Aug;104(8):1135-8. doi: 10.1111/cas.12180.
9
Adenomatous polyposis coli and Asef function downstream of hepatocyte growth factor and phosphatidylinositol 3-kinase.腺瘤性结肠息肉病蛋白和Asef在肝细胞生长因子和磷脂酰肌醇3激酶的下游发挥作用。
J Biol Chem. 2009 Aug 14;284(33):22436-22443. doi: 10.1074/jbc.M109.020768. Epub 2009 Jun 12.
10
The adenomatous polyposis coli-associated guanine nucleotide exchange factor Asef is involved in angiogenesis.腺瘤性结肠息肉病相关鸟嘌呤核苷酸交换因子 Asef 参与血管生成。
J Biol Chem. 2010 Jan 8;285(2):1199-207. doi: 10.1074/jbc.M109.040691. Epub 2009 Nov 6.

引用本文的文献

1
Predicting colorectal cancer risk in FAP patients using patient-specific organoids.使用患者特异性类器官预测家族性腺瘤性息肉病患者的结直肠癌风险。
Cancer Gene Ther. 2025 Jul 22. doi: 10.1038/s41417-025-00923-7.
2
Potentials of N-Acyl Hydrazones Against Colorectal Cancer: A Mini Review.N-酰基腙类化合物抗结直肠癌的潜力:一篇综述
Anticancer Agents Med Chem. 2025;25(17):1273-1286. doi: 10.2174/0118715206356253241223040825.
3
Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy.通过STELLA定义用于癌症治疗的直系同源物特异性UHRF1抑制作用。

本文引用的文献

1
The loss-of-function mutations and down-regulated expression of ASB3 gene promote the growth and metastasis of colorectal cancer cells.ASB3基因的功能丧失突变和表达下调促进结肠癌细胞的生长和转移。
Chin J Cancer. 2017 Jan 14;36(1):11. doi: 10.1186/s40880-017-0180-0.
2
Peptidomimetic therapeutics: scientific approaches and opportunities.拟肽疗法:科学方法与机遇
Drug Discov Today. 2017 Feb;22(2):454-462. doi: 10.1016/j.drudis.2016.11.003. Epub 2016 Nov 14.
3
Therapeutic design of peptide modulators of protein-protein interactions in membranes.
Nat Commun. 2025 Jan 8;16(1):474. doi: 10.1038/s41467-024-55481-7.
4
Rational design of small-sized peptidomimetic inhibitors disrupting protein-protein interaction.破坏蛋白质-蛋白质相互作用的小型拟肽抑制剂的合理设计。
RSC Med Chem. 2024 May 7;15(7):2212-2225. doi: 10.1039/d4md00202d. eCollection 2024 Jul 17.
5
Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives.新型 1,2,3-三唑连接四氢姜黄素衍生物的合成、抗癌活性及分子对接。
Molecules. 2024 Jun 25;29(13):3010. doi: 10.3390/molecules29133010.
6
Computer-aided molecular design and optimization of potent inhibitors disrupting APC‒Asef interaction.破坏APC-Asef相互作用的强效抑制剂的计算机辅助分子设计与优化
Acta Pharm Sin B. 2024 Jun;14(6):2631-2645. doi: 10.1016/j.apsb.2024.03.020. Epub 2024 Mar 19.
7
Correlation of Experimental and Calculated Inhibition Constants of Protease Inhibitor Complexes.实验和计算的蛋白酶抑制剂复合物抑制常数的相关性。
Int J Mol Sci. 2024 Feb 19;25(4):2429. doi: 10.3390/ijms25042429.
8
On-Resin Photochemical Decarboxylative Arylation of Peptides.树脂上光化学脱羧芳基化肽。
Org Lett. 2024 Apr 12;26(14):2795-2799. doi: 10.1021/acs.orglett.3c03070. Epub 2023 Oct 11.
9
Spatiotemporal Coordination of Rac1 and Cdc42 at the Whole Cell Level during Cell Ruffling.细胞皱襞过程中 Rac1 和 Cdc42 在全细胞水平上的时空协调
Cells. 2023 Jun 15;12(12):1638. doi: 10.3390/cells12121638.
10
Targeting Protein-Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches.靶向蛋白质-蛋白质界面的肽:化学组合肽文库方法的贡献。
Int J Mol Sci. 2023 Apr 25;24(9):7842. doi: 10.3390/ijms24097842.
膜蛋白-蛋白相互作用肽调节剂的治疗设计。
Biochim Biophys Acta Biomembr. 2017 Apr;1859(4):577-585. doi: 10.1016/j.bbamem.2016.08.013. Epub 2016 Aug 28.
4
Loss of ZFP36 expression in colorectal cancer correlates to wnt/ ß-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of ZEB1, SOX9 and MACC1.结直肠癌中ZFP36表达缺失与Wnt/β-连环蛋白活性相关,并通过上调ZEB1、SOX9和MACC1增强上皮-间质转化。
Oncotarget. 2016 Sep 13;7(37):59144-59157. doi: 10.18632/oncotarget.10828.
5
miR186 suppresses prostate cancer progression by targeting Twist1.微小RNA-186通过靶向Twist1抑制前列腺癌进展。
Oncotarget. 2016 May 31;7(22):33136-51. doi: 10.18632/oncotarget.8887.
6
CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil.CETSA筛选鉴定出已知和新型胸苷酸合成酶抑制剂以及5-氟尿嘧啶的缓慢细胞内激活。
Nat Commun. 2016 Mar 24;7:11040. doi: 10.1038/ncomms11040.
7
SUMOylation of TARBP2 regulates miRNA/siRNA efficiency.TARBP2的类泛素化修饰调节miRNA/siRNA的效率。
Nat Commun. 2015 Nov 19;6:8899. doi: 10.1038/ncomms9899.
8
The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies.细胞热转移分析:一种用于药物靶标原位结合及机制生物标志物研究的新型生物物理分析方法。
Annu Rev Pharmacol Toxicol. 2016;56:141-61. doi: 10.1146/annurev-pharmtox-010715-103715. Epub 2015 Nov 9.
9
Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays.使用细胞热迁移分析评估Mdm2/Mdm4抑制性环肽的疗效。
Sci Rep. 2015 Jul 10;5:12116. doi: 10.1038/srep12116.
10
Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.基于结构的蛋白质-蛋白质相互作用抑制剂设计:模拟肽结合表位
Angew Chem Int Ed Engl. 2015 Jul 27;54(31):8896-927. doi: 10.1002/anie.201412070. Epub 2015 Jun 26.